Slides
Page 1
Q3 2026 Earnings Call November 5, 2026
Page 2
Cautionary Statements Unless otherwise indicated, references in this presentation to “CareRx”, the “Company”, “we”, “our”, “us”, or similar terms refers to CareRx Corporation, together with its subsidiaries. Any information demonstrating our historical performance is intended only to reflect past performance and may not be indicative of our future performance. Investors should not assume that the information contained in this presentation is accurate as of any date other than the date of this presentation, or where information is stated to be as of a date other than the date given, such other applicable date. Unless otherwise stated, all amounts in this presentation are stated in Canadian dollars and references to “$” or “dollars” are to Canadian dollars. Forward Looking Statements Certain of the statements contained in this presentation are "forward-looking statements” within the meaning of applicable Canadian securities legislation. Forward-looking statements in this presentation include, but are not limited to, statements about the Company’s objectives, outlook, business strategy, plans and other expectations, beliefs, goals, intentions and statements about possible future events. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “outlook ”, “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “positioned”, “should”, “plans” or “continue”, or similar expressions suggesting future outcomes or events. Such forward-looking statements reflect management's current beliefs and are based on information available to management as of the date of this presentation. The forward-looking statements are included for the purpose of providing management’s perspective on the Company’s anticipated future operating performance, and such forward-looking statements may not be appropriate for other purposes. Readers are cautioned not to place undue reliance on forward-looking statements. Such statements are based on management’s perception of historical trends, current conditions, and future developments, as well as assumptions that, while considered reasonable by management as of the date hereof, are inherently subject to known and unknown risks and uncertainties (many of which are beyond the control of the Company) that could cause actual results to differ materially from those contemplated by such statements. Factors and risks that could cause actual results to differ from those anticipated by management and set out in the forward-looking statements include, but are not limited to, those set out in the section “Risks Factors” in the Company’s Management’s Discussion and Analysis for the three- and nine-month periods ended September 30, 2026 and 2025, available on the Company’s SEDAR+ profile at www.sedarplus.ca. As a result of the foregoing and other factors, no assurance can be given that as to the Company’s future results, levels of activity or performance. Other than as specifically required by applicable laws, the Company is under no obligation and it expressly disclaims any such obligation to update or alter the forward-looking statements, whether as a result of new information, future events or otherwise. All forward-looking statements in this press release are qualified by these cautionary statements. Non-IFRS Financial Measures and Other Financial Measures This presentation references certain non-IFRS measures, non-IFRS ratios and other financial measures. “EBITDA”, “Adjusted EBITDA”, and “Net Debt” are non-IFRS measures, and “Adjusted EBITDA Margin” and “Net Debt to Adjusted EBITDA” are non-IFRS ratios. “Average Beds Serviced” is a supplementary financial measure. These measures are not standardized financial measures under IFRS and readers are cautioned that these measures may not be comparable to similar measures disclosed by other issuers. Net income (loss) is the IFRS measure most directly comparable to EBITDA and Adjusted EBITDA. Cash and cash equivalents and Borrowings are the IFRS measures which make up and are most directly comparable to Net Debt. "Adjusted EBITDA Margin" is defined as Adjusted EBITDA divided by revenue. "Net Debt to Adjusted EBITDA" is defined as Net Debt divided by the Company's run-rate Adjusted EBITDA annualized based on the current quarter's Adjusted EBITDA. The non-IFRS measures, non-IFRS ratios and supplementary financial measures in this presentation should not be viewed as a substitute for the related financial information prepared in accordance with IFRS. For information on the composition of each non-IFRS measure, non-IFRS ratio and supplementary financial measure, a description of how we use these measures or how they provide useful information to investors, and applicable reconciliations to IFRS measures, refer to the sections “Non-IFRS Financial Measures” , “Non-IFRS Ratios”, “Key Performance Indicators” and “Reconciliation of Non-IFRS Measures” in the Company’s Management’s Discussion and Analysis for the three- and nine-month periods ended September 30, 2026 and 2025, available on the Company’s SEDAR+ profile at www.sedarplus.ca. 2
Page 3
Highlights and Growth Momentum Puneet Khanna President & Chief Executive Officer
Page 4
1. Adjusted EBITDA is a non-IFRS financial measure and Adjusted EBITDA Margin is a non-IFRS ratio. Average Beds Serviced is a is a supplementary financial measure. See “Non-IFRS Financial Measures and Other Financial Measures” for further information. All figures are for the three-month period ended September 30, 2026. Q3 2026 Summary $0.2 Million Net Income $95.3 Million Revenue 8.5% Adjusted EBITDA Margin1 $8.1 Million Adjusted EBITDA1 93,225 Average Beds Serviced1
Page 5
Business Highlights • Onboarded a new national customer, adding approximately 3,000 new beds • Announced comprehensive refinancing transaction • Renewed NCIB, repurchased approximately 258,000 shares since September 1, 2026 • Declared quarterly dividend of $0.022 per Common Share
Page 6
Operating and Financial Results Suzanne Brand Chief Financial Officer
Page 7
Q3 2026 Financial Results 7 Average Beds Serviced1 93,225 vs 91,298 in Q3 2025 Revenue $95.3 million vs $93.2 million in Q3 2025 Adjusted EBITDA1 $8.1 million vs $8.3 million in Q3 2025 Adjusted EBITDA Margin1 8.5% vs 9.0% in Q3 2025 Net Income $0.2 million vs $1.6 million in Q3 2025 Cash from Operations $6.5 million vs $10.1 million in Q3 2025 • Revenue increase primarily driven by growth in beds serviced • Adjusted EBITDA¹ and Adjusted EBITDA Margin1 decreased due to the ward bed changes and labour cost increases, largely offset by expense management • Net Income decreased mainly due to the utilization of deferred tax assets and transaction costs of the Company’s refinancing 1. Average Beds Serviced is a supplementary financial measure. Adjusted EBITDA is a non-IFRS financial measure and Adjusted EBITDA Margin is a non-IFRS ratio. See “Non-IFRS Financial Measures and Other Financial Measures” for further information. As at September 30, 2026
Page 8
Q3 2026 Balance Sheet 8 Cash $10.7 million vs $9.6 million at Q2 2026 Net Debt1 $29.6 million vs $29.1 million at Q2 2026 Net Debt to Adjusted EBITDA1 0.9x vs 0.9x at Q2 2026 1. Net Debt is a non-IFRS financial measure and Net Debt to Adjusted EBITDA is a non-IFRS ratio. See “Non-IFRS Financial Measures and Other Financial Measures” for further information. As at September 30, 2026 • Renewed NCIB and repurchased 258,000 shares between September 1 and October 31, 2026. • Closed refinancing transaction with National Bank • Subsequent to quarter-end, dividend payment of $1.4 million on October 8, 2026
Page 9
Final Perspectives Puneet Khanna President & Chief Executive Officer
Page 10
Final Perspectives 10 • Partnered with Haleon on a joint initiative to provide ~5,000 seniors across Canada with Centrum 50+ multivitamins • Participated in LTC Community Engagement Day events, with team members joining residents and care teams throughout Ontario • Received the Canadian Foundation for Pharmacy’s 2026 Innovation in Vaccine Services Award for developing flexible vaccination programs tailored to the needs of individual communities